Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin's lymphoma

Annals of Hematology

Volumn 84, Issue 11, 2005, Pages 742-747

  Kim, Shin ^a   Kim, Hyo Jung ^b   Park, Jung Sun ^a   Lee, Jungsin ^a   Chi, Hyun Sook ^a   Park, Chan Jeong ^a   Huh, Jooryung ^a   Suh, Cheolwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Autologous stem cell transplantation; G CSF; Mobilization; Multiple myeloma; Non Hodgkin's lymphoma

Indexed keywords

ACICLOVIR; CARMUSTINE; CD34 ANTIGEN; CIPROFLOXACIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG FATALITY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; INFECTION; LYMPHOCYTE COUNT; MALE; MULTIPLE MYELOMA; MYALGIA; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RECOMBINANT PROTEINS;

EID: 26844502883     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1103-8     Document Type: Article

References (24)

1. Perez-Simon JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L, Amigo ML, Berges C, Gonzalez M, Canizo C, Miguel JF (1998) Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 38:385-391
2. Feugier P, Bensoussan D, Girard F, Alla F, Schuhmacher A, Latger-Cannard V, Hulin C, Witz F, Witz B, Carret AS, Bordigoni P, Lederlin P, Janot C (2003) Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells. Transfusion 43:8780-884
3. André M, Baudoux E, Bron D, Canon JL, D'Hondt V, Fassotte MF, D'Hondt L, Fillet G, Humblet Y, Jerusalem G, Vermeulen V, Symann M, Beguin Y (2003) Phase III randomized study comparing 5 or 10 g per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion 43:50-57
4. Carrion R, Serrano D, Gomez-Pineda A, Diez-Martin JL (2003) A randomised study of 10 ug/kg/day (single dose) vs 2×5 ug/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients. Bone Marrow Transplant 32:563-567 10.1038/sj.bmt.1704202
5. Arbona C, Prosper F, Benet I, Mena F, Solano C, Garcia-Conde J (1998) Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantation. Bone Marrow Transplant 22:39-45 10.1038/ sj.bmt.1701293
6. Kröger N, Renges H, Kruger W, Gutensohn K, Loliger C, Carrero I, Cortes L, Zander AR (2000) A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 111:761-765
7. Lee V, Li CK, Shing MMK, Chik KW, Li K, Tsang KS, Zhao DC, Lai DH, Wong A, Yuen PMP (2000) Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases. Bone Marrow Transplant 25:931-935 10.1038/sj.bmt.1702338
8. Anderlini P, Donato M, Lauppe MJ, Huh YO, Martin TG, Chan KW, Champlin RE, Korbling M (2000) A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors. Br J Haematol 109:770-772
9. Kröger N, Sonnenberg S, Cortes-Dericks L, Freiberger P, Mollnau H, Zander AR (2004) Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: An intraindividual crossover study. Transfusion 44:104-110 10.1111/j.0041-1132.2004.00618.x
10. Kröger N, Zeller W, Hassan HT, Kröger W, Gutensohn K, Löliger C, Zander AR (1999) Stem cell mobilization with G-CSF alone in breast cancer patients: Higher progenitor cell yield by delivering divided doses (2×5 ug/kg) compared to a single dose (1 10 ug/kg). Bone Marrow Transplant 23:125-129 10.1038/sj.bmt.1701549
11. Lee JL, Kim S, Kim SW, Kim EK, Kim SB, Kang YK, Lee J, Kim MW, Park CJ, Chi HS, Huh J, Kim SH, Suh C (2005) ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: Comparison with high-dose cyclophosphamide plus G-CSF. Bone Marrow Transplant 35:449-454
12. Suh C, Kim S, Kim SH, Kim EK, Lee JL, Park KU, Park JS, Lee JS, Kim WK, Chi HS, Park CJ, Kim SW (2004) Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000. Transfusion 44:1762-1768 10.1111/ j.0041-1132.2004.04166.x
13. Park KU, Kim SH, Suh C, Kim S, Lee SJ, Park JS, Cho HJ, Kim KW, Lee K, Kim HJ, Park J, Min YJ, Kim JG, Kim T, Lee JH, Kim SB, Kim SW, Lee KH, Lee JS, Kim WK, Park CJ, Chi HS (2001) Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34+ cell count by flow cytometry in leukapheresis products. Am J Hematol 67:42-47 10.1002/ajh.1074
14. Lee JL, Kim S, Lee GW, Ryu MH, Kim EK, Kim S, Kim WK, Lee JS, Park KU, Suh C (2003) Clinical usefulness of hematopoietic progenitor cell counts in predicting optimal timing of peripheral blood stem cell harvest. J Korean Med Sci 18:27-35 12589083
15. Lee JL, Kim S, Lee GW, Ryu MH, Kim E, Kim S, Kim WK, Lee JS, Kim SH, Suh C (2003) The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma. Yonsei Med J 44:800-0810 14584095
16. Caballero MD, Rubio V, Rifon J, Heras I, García-Sanz R, Vázquez L, Vidriales B, del Cañizo MC, Corral M, Gonzalez M, León A, Jean-Paul E, Rocha E, Moraleda JM, San Miguel JF (1997) BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 20:451-458 10.1038/sj.bmt.1700913
17. Socinski MA, Elias A, Schnipper L, Cannistra SA, Antman KH, Griffin JD (1988) Granulocyte macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 331:1194-1198 10.1016/S0140-6736(88)92012-0
18. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081 3264199
19. Russell NH, McQuaker G, Stainer C, Byrne JL, Haynes AP (1998) Stem cell mobilisation in lymphoproliferative diseases. Bone Marrow Transplant 22:935-940 10.1038/sj.bmt.1701477
20. Kessinger A, Sharp JG (2003) The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant 31:319-329 10.1038/sj.bmt.1703837
21. Lee JL Kim S, Lee GW, Ryu MH, Kim EK, Kim S, Kim WK, Lee JS, Suh C (2003) Collection of peripheral blood progenitor cells: Analysis of factors predicting the yields Transfus Apher Sci 29:29-37 10.1016/ S1473-0502(03)00097-1
22. Koenigsmann M, Jentsch-Ullrich K, Mohren M, Becker E, Heim M, Franke A (2004) The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion 44:777-784 10.1111/ j.0041-1132.2004.03321.x
23. Fruehauf S, Seggewiss R (2003) It's moving day: Factors affecting peripheral blood stem mobilization and strategies for improvement. Br J Haematol 122:360-375 10.1046/j.1365-2141.2003.04483.x
24. Martin-Murea S, Voso MT, Hohaus S, Pforsich M, Fruehauf S, Goldschmidt H, Hegenbart U, Haas R (1998) The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haematopoietic progenitor cells during marrow recovery. Br J Haematol 101:582-585 10.1046/ j.1365-2141.1998.00730.x